Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Brepocitinib, Zimlovisertib, and Ropsacitinib in Hidradenitis Suppurativa
Alexa B. Kimball, Elena Peeva, Seth Forman, et al.
NEJM Evidence (2024) Vol. 3, Iss. 3
Closed Access | Times Cited: 13

Showing 13 citing articles:

An evolutionary tale on clinical trials in hidradenitis suppurativa
Christopher Sayed, Rayad B. Shams, Bria Midgette, et al.
British Journal of Dermatology (2025) Vol. 192, Iss. Supplement_1, pp. i15-i21
Open Access | Times Cited: 1
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
Yaoxiang Lin, Lulu Zheng, Ying Xu, et al.
Journal of Medicinal Chemistry (2025) Vol. 68, Iss. 2, pp. 902-914
Closed Access
Future Directions and Pipeline Therapies for Hidradenitis Suppurativa
Kim Thuy Nguyen, Daniella Jaguan, Noah Goldfarb
Dermatologic Clinics (2025) Vol. 43, Iss. 2, pp. 359-371
Closed Access
Unlocking disease insights to facilitate drug development: Pharmaceutical industry–academia collaborations in inflammation and immunology
Elena Peeva, Emma Guttman‐Yassky, Yuji Yamaguchi, et al.
Drug Discovery Today (2025), pp. 104317-104317
Closed Access
Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition
Martina Dragotto, Martina D’Onghia, Emanuele Trovato, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 11, pp. 3091-3091
Open Access | Times Cited: 3
Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development
Elena Peeva, Anindita Banerjee, Christopher Banfield, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 5, pp. 103948-103948
Open Access | Times Cited: 2
Hidradenitis suppurativa: key insights into treatment success and failure
Kelsey R. van Straalen, Vincent Piguet, Jóhann E. Guðjónsson
Journal of Clinical Investigation (2024) Vol. 134, Iss. 21
Open Access | Times Cited: 2
Data wobbles in hidradenitis suppurativa clinical trials and potential contributing factors: a retrospective review
Corey L. Snyder, Ruby S. Gibson, Stella Chen, et al.
International Journal of Women’s Dermatology (2024) Vol. 10, Iss. 2, pp. e152-e152
Open Access | Times Cited: 1
Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
Martina D’Onghia, Dalma Malvaso, Giulia Galluccio, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 17, pp. 5211-5211
Open Access | Times Cited: 1
Review of Janus Kinase Inhibitors as Therapies for Noninfectious Uveitis
Hui Yu Juan, Shwu‐Jiuan Sheu, De‐Kuang Hwang
Journal of Ocular Pharmacology and Therapeutics (2024)
Closed Access | Times Cited: 1
Januskinaseinhibitoren für dermatologische Erkrankungen
Farzan Solimani, Kamran Ghoreschi
Deleted Journal (2024)
Closed Access
Immunomodulators and Biologics for Follicular and Neutrophilic Cutaneous Disorders
Mavra Masood, Iltefat Hamzavi
Springer eBooks (2024), pp. 125-146
Closed Access
The role of IL-1 family cytokines in diabetic cardiomyopathy
Qi Wu, Yan Zeng, Kang Geng, et al.
Metabolism (2024), pp. 156083-156083
Closed Access
Page 1

Scroll to top